Medacta Group (6MD) Stock Overview
Develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for 6MD from our risk checks.
6MD Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Medacta Group SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 139.00 |
| 52 Week High | CHF 191.40 |
| 52 Week Low | CHF 133.00 |
| Beta | 0.99 |
| 1 Month Change | -1.42% |
| 3 Month Change | -14.72% |
| 1 Year Change | -5.95% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 59.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6MD | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -4.8% | -0.1% | 0.1% |
| 1Y | -6.0% | -26.5% | -0.5% |
Return vs Industry: 6MD exceeded the German Medical Equipment industry which returned -25.4% over the past year.
Return vs Market: 6MD underperformed the German Market which returned 0.3% over the past year.
Price Volatility
| 6MD volatility | |
|---|---|
| 6MD Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 12.7% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: 6MD has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 6MD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 2,036 | Francesco Siccardi | www.medacta.com |
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Medacta Group SA Fundamentals Summary
| 6MD fundamental statistics | |
|---|---|
| Market cap | €2.79b |
| Earnings (TTM) | €95.46m |
| Revenue (TTM) | €683.83m |
Is 6MD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6MD income statement (TTM) | |
|---|---|
| Revenue | €683.83m |
| Cost of Revenue | €225.17m |
| Gross Profit | €458.66m |
| Other Expenses | €363.20m |
| Earnings | €95.46m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Sep 09, 2026
| Earnings per share (EPS) | 4.79 |
| Gross Margin | 67.07% |
| Net Profit Margin | 13.96% |
| Debt/Equity Ratio | 44.9% |
How did 6MD perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/22 18:26 |
| End of Day Share Price | 2026/07/22 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medacta Group SA is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| David Adlington | J.P. Morgan |
| Ilya Burgansky | Research Partners AG |